Application Sponsors
ANDA 210984 | INGENUS PHARMS LLC | |
Marketing Status
Application Products
001 | INJECTABLE;INTRAVENOUS | 50MG/VIAL | 0 | DECITABINE | DECITABINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-09-16 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2021-03-17 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2021-03-17 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 2 | Null | 15 |
SUPPL | 4 | Null | 7 |
TE Codes
CDER Filings
INGENUS PHARMS LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 210984
[companyName] => INGENUS PHARMS LLC
[docInserts] => ["",""]
[products] => [{"drugName":"DECITABINE","activeIngredients":"DECITABINE","strength":"50MG\/VIAL","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"09\/16\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-09-16
)
)